6 stocks to watch 1:35 p.m. Oct. 29, 2014 - The Trading Deck
Six stocks to watch 12:47 p.m. Aug. 27, 2014 - The Trading Deck
Six stocks to watch 2:46 p.m. July 2, 2014 - The Trading Deck
6 stocks to watch 2:50 p.m. June 11, 2014 - The Trading Deck
Stock leaders flex muscles 1:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 11:28 a.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 11:23 a.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 1:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 10:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 10:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 2:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 7:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 2:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 11:26 a.m. Feb. 24, 2012 - MarketWatch.com
Biggest Movers in Healthcare Stocks Now – ARIA PTCT PTCT CLDX 6:30 a.m. Nov. 24, 2014 - InvestorPlace.com
Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind 6:00 a.m. Nov. 21, 2014 - TheStreet.com
Celldex Therapeutics (CLDX) Stock Rises Today on High Volume 12:06 p.m. Nov. 20, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA KND MDCO 6:45 a.m. Nov. 20, 2014 - InvestorPlace.com
This Biotech Stock Is Ready To Run 5:12 p.m. Nov. 19, 2014 - benzinga.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Hottest Healthcare Stocks Now – CLDX AVNR AUXL AZN 6:15 a.m. Nov. 19, 2014 - InvestorPlace.com
Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog 5:05 p.m. Nov. 18, 2014 - Zacks.com
Why Celldex Therapeutics' Stock Is Now Ready For Takeoff 2:44 p.m. Nov. 18, 2014 - Seeking Alpha
Mid-Day Losers From November 18: Omega Protein, Urban Outfitters, Celldex Therapeutics, Amicus Therapeutics, Inter Parfums 11:58 a.m. Nov. 18, 2014 - benzinga.com
Celldex Therapeutics (CLDX) Stock Sells Off Today Following Monday's Gains 11:47 a.m. Nov. 18, 2014 - TheStreet.com
Celldex Therapeutics To Enter Talks With FDA 10:26 a.m. Nov. 18, 2014 - Seeking Alpha
Perilous Reversal Stock: Celldex Therapeutics (CLDX) 9:51 a.m. Nov. 18, 2014 - TheStreet.com
Celldex Therapeutics, Inc. (CLDX) in Focus: Stock Soars 28.9% - Tale of the Tape 9:18 a.m. Nov. 18, 2014 - Zacks.com
Midday Gainers From November 17: Celldex Therapeutics, Amicus Therapeutics, Baker Hughes, Allergan 11:34 a.m. Nov. 17, 2014 - benzinga.com
Celldex Therapeutics (CLDX) Stock Surges Following Brain Tumor Immunotherapy Results 11:02 a.m. Nov. 17, 2014 - TheStreet.com
Celldex Therapeutics: Interim Results For Phase 2 ReACT Trial Are Very Encouraging 10:28 a.m. Nov. 17, 2014 - Seeking Alpha
Celldex Therapeutics Jumps 25% Amid Brain Cancer Study 9:47 a.m. Nov. 17, 2014 - benzinga.com
Heavy Early Morning Activity On Celldex Therapeutics (CLDX) 8:59 a.m. Nov. 17, 2014 - TheStreet.com
Celldex up premarket on positive rindopepimut data 8:57 a.m. Nov. 17, 2014 - Seeking Alpha
Critical Alerts For Kinder Morgan, Celldex Therapeutics, Baker Hughes Inc., RF Micro Devices and SolarCity Released By InvestorsObserver 9:31 a.m. Nov. 18, 2014 - PR Newswire - PRF
Biotech Equities Technical Coverage - Orexigen Therapeutics, Novavax, Sunesis Pharma, Celldex Therapeutics, and Navidea Biopharma 8:45 a.m. Nov. 17, 2014 - PR Newswire - PRF
Interim Update from Randomized Phase 2 ReACT Study of Rindopepimut in Recurrent Bevacizumab-naive Glioblastoma Demonstrates Statistically Significant Survival Benefit 3:35 p.m. Nov. 14, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. Nov. 11, 2014 - PR Newswire - PRF
Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab 4:07 p.m. Nov. 10, 2014 - GlobeNewswire
Celldex Presents Varlilumab Proof of Concept Data at SITC Annual Meeting 2014 10:02 a.m. Nov. 7, 2014 - GlobeNewswire
Celldex Therapeutics Announces Upcoming Presentations of Rindopepimut Data at 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) 7:02 a.m. Nov. 3, 2014 - GlobeNewswire
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
Celldex Announces Publication of Glembatumumab Vedotin Phase 1/2 Studies in the Journal of Clinical Oncology 3:08 p.m. Sept. 30, 2014 - GlobeNewswire
Celldex Therapeutics Initiates Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Transplantation 7:05 a.m. Sept. 25, 2014 - GlobeNewswire
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the Morgan Stanley Healthcare Conference 1:01 p.m. Sept. 3, 2014 - GlobeNewswire
Critical Alerts For General Electric, DSW, Celldex Therapeutics, Cognizant Technology Solutions and 3M Released By InvestorsObserver 8:31 a.m. Aug. 27, 2014 - PR Newswire - PRF
Small companies lead the I-O class of Cancer Therapies 7:03 a.m. Aug. 8, 2014 - ACCESSWIRE
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 7:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Celldex Therapeutics Announces Senior Leadership Promotions 7:03 a.m. July 30, 2014 - GlobeNewswire
Celldex to Report Second Quarter 2014 Financial Results and Host Corporate 2014 Objectives Update Call 7:03 a.m. July 18, 2014 - GlobeNewswire
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 3:55 p.m. July 15, 2014 - PR Newswire - PRF
Critical Alerts For SolarCity, DreamWorks Animation, Celldex Therapeutics, BP, and Universal Display Corporation Released By InvestorsObserver 8:31 a.m. July 8, 2014 - PR Newswire - PRF
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 4:30 a.m. July 4, 2014 - PR Newswire - PRF